← back to search

Sridhar Ramaswamy

Harvard University · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include RNA modifications and cancer, Cancer Cells and Metastasis, Cancer Genomics and Diagnostics, and Melanoma and MAPK Pathways.
h-index
80
citations
55,474
works
394
NIH funding
primary concept
email

Recent publications

Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of <i>BRCA2</i> mutation carriers
Science Advances 2020cited by 44position: middledoi
The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing
Molecular Cell 2019cited by 70position: middledoi
COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis
Proceedings of the National Academy of Sciences 2019cited by 48position: middledoi
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
Proceedings of the National Academy of Sciences 2018cited by 130position: middledoi
AR Expression in Breast Cancer CTCs Associates with Bone Metastases
Molecular Cancer Research 2018cited by 109position: middledoi
Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination
Nature Communications 2017cited by 142position: middledoi
E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression
Developmental Cell 2017cited by 27position: middledoi
HER2 expression identifies dynamic functional states within circulating breast cancer cells
Nature 2016cited by 407position: middledoi
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b
Cell 2016cited by 321position: middledoi
Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition
Cell Reports 2016cited by 131position: middledoi
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
Nature 2015cited by 788position: middledoi
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
Nature Methods 2015cited by 720position: middledoi
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
Science 2015cited by 716position: middledoi
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Nature Communications 2015cited by 632position: middledoi
Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer
Proceedings of the National Academy of Sciences 2015cited by 187position: middledoi
The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine
Nature Cell Biology 2015cited by 155position: middledoi
Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer
Proceedings of the National Academy of Sciences 2015cited by 130position: middledoi
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
PLoS ONE 2015cited by 53position: middledoi
MAPK7 Regulates EMT Features and Modulates the Generation of CTCs
Molecular Cancer Research 2015cited by 46position: middledoi
The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28
Journal of Biological Chemistry 2015cited by 22position: middledoi
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Cell 2014cited by 2,460position: middledoi
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Science 2014cited by 910position: middledoi
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nature 2014cited by 895position: middledoi
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Science 2014cited by 733position: middledoi
Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells
Cell Reports 2014cited by 540position: middledoi
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Nature 2014cited by 467position: middledoi
Isolation and Molecular Characterization of Circulating Melanoma Cells
Cell Reports 2014cited by 108position: middledoi
Bioengineered Implantable Scaffolds as a Tool to Study Stromal-Derived Factors in Metastatic Cancer Models
Cancer Research 2014cited by 62position: middledoi
Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation
The Journal of Experimental Medicine 2014cited by 52position: middledoi
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Science 2013cited by 2,455position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel A. Haber · Rambam Health Care Campus22 papers (2012–2019)Shyamala Maheswaran · Harvard University19 papers (2012–2019)David T. Ting · Harvard University17 papers (2012–2019)Ben S. Wittner · Harvard University17 papers (2012–2019)Mehmet Toner · Shriners Hospitals for Children - Erie15 papers (2012–2019)Min Yu · University of Maryland, Baltimore10 papers (2012–2017)Toshi Shioda · Center for Cancer Research8 papers (2013–2019)David T. Miyamoto · Harvard University8 papers (2012–2019)Ravi Kapur · Biocon (India)7 papers (2014–2018)Brian W. Brannigan · Harvard University7 papers (2012–2015)Shannon L. Stott · Broad Institute7 papers (2012–2015)Lecia V. Sequist · Harvard University7 papers (2012–2018)Rushil Desai · Harvard University7 papers (2013–2017)Aditya Bardia · Comprehensive Blood & Cancer Center6 papers (2013–2018)Nicola Aceto · ETH Zurich6 papers (2014–2018)Yu Zheng · Yibin University6 papers (2015–2019)Robert Morris · Center for Cancer Research5 papers (2013–2017)Wilhelm Haas · Harvard University5 papers (2015–2017)Kenneth N. Ross · Massachusetts Institute of Technology5 papers (2015–2020)Francesca Bersani · Center for Cancer Research5 papers (2013–2018)